Home > Income Statement > ALEMBIC

ALEMBIC
Revenue

    Back to Income Statement
ALEMBIC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ALEMBIC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹222 Cr₹157 Cr₹127 Cr₹78 Cr₹74 Cr

What is the latest Revenue of ALEMBIC ?

The latest Revenue ratio of ALEMBIC is ₹222 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹222 Cr
Mar2024₹157 Cr
Mar2023₹127 Cr
Mar2022₹78 Cr
Mar2021₹74 Cr

How is Revenue of ALEMBIC Trending?

Years Revenue % Change
Mar2025 ₹222 Cr
40.89
Mar2024 ₹157 Cr
23.77
Mar2023 ₹127 Cr
62.68
Mar2022 ₹78 Cr
6.40
Mar2021 ₹74 Cr -

Compare Revenue of peers of ALEMBIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC ₹2,092.7 Cr -6.3% -16.9% -15.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -1.6% 5.7% 7.7% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -4.2% -1.4% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -2.8% 5.7% 39.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -3.2% 1.2% 14.2% Stock Analytics
CIPLA ₹102,443.0 Cr -3.6% -3.7% -10.2% Stock Analytics


ALEMBIC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC

-6.3%

-16.9%

-15.3%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses